Risk of developing malignancy in congenital choledochal malformation

“Malignancies develop in 2⋅5–26 per cent of patients with choledochal malformation. Choledochal malformations are classified according to Todani and colleagues.
Several authors consider the development of malignancy in choledochal malformations to be related to the aetiology of the different types of malformation. It could be speculated that prolonged reflux of pancreatic secretions into the biliary tract occurs in Todani types I and IV,
which frequently present with abnormal pancreaticobiliary duct junctions. Prolonged reflux might lead to malignant degeneration of the biliary epithelium. The situation is supposedly different in types II and III choledochal malformations, which might be true congenital malformations in which reflux is absent”

Continue reading

What is the classification of choledochal cysts?

Choledochal Cyst. In: Doherty GM. eds. Quick Answers Surgery. McGraw-Hill; Accessed April 02, 2021. 

  • Type I cysts (fusiform dilation of common bile duct [CBD]) account for 85-90%
  • Type II (true diverticula of CBD) 1-2% of cases
  • Type III (choledochocele—dilation of distal/intramural portion of CBD) < 2% of cases
  • Type IV (multiple cysts involving intrahepatic and extrahepatic ducts) as high as 15% of cases in some series
  • Type V (cystic malformation of intrahepatic ducts) rare
  • 3-5% incidence of carcinoma
Continue reading